Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06561087
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-16
Brief Title:
Phase II Randomized Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions
Sponsor:
Organization:
None